18067_LAPIPCaseStudyJPG

Register to receive a free U.S. Dental Lasers Market report synopsis and brochure

Millennium Dental Technologies, Inc. announced that it has filed a new patent application on innovations in its LAPIP™ protocol and PerioLase® MVP-7™ dental laser. This initiative is part of its ongoing commitment to the fight against gum disease around teeth and implants through state-of-the-art technologies and patient-friendly protocols.

“The LAPIP™ protocol is a ground-breaking clinical procedure for treatment of peri-mucositis and peri-implantitis around titanium implants,” said Robert Gregg, DDS, founder of Millennium Dental Technologies and innovator of the LAPIP™ protocol.

Dental implants were seen originally as a long-term replacement for teeth, and millions are placed annually. With current dental implant failure rates over 16 percent and rising, patients are being subjected to highly invasive surgeries in an attempt to save these ailing and failing implants. The LAPIP™ protocol is a tissue-sparing, non-destructive, minimally invasive treatment.

Other dental lasers in the market include those by Fotona. At this year’s International Dental Show (IDS) held in Cologne, Germany, Ilay Maden, DMD, MSc, PhD presented on advanced treatment of peri-implantitis using the Lightwalker ATS Erbium and Nd:YAG dental laser (Fotona, www.fotona.com).

In his presentation, Dr. Maden noted, “As the number of dental implants being placed increases, even though many keep quiet about it, the reported number of cases with peri-implantitis is also increasing. The main cause of peri-implantitis is the colonisation of pathogen bacteria and the difficulty in cleaning the rough surface of implants.”

 

“Using the Lightwalker’s Er:YAG 2940nm wavelength, it is possible to clean the granulation tissues, both on the bone and implant surfaces, and thoroughly decontaminate the infected site. The erbium laser targets the water content to remove the granulation tissue selectively, due to its ability to use long pulse durations and lower peak power, while ablating the microorganisms on the surface of the bone. The bactericidal effect of low power Er:YAG on the surgical site is also effective against endotoxins and lipopolysaccharides, which provides the complete cleansing of the implant surface without chemicals or any surface modification on the implant. Er:YAG is used again with shorter pulse durations to activate bleeding and decorticating the bony wall of the defect.”

Dental implants were seen originally as a long-term replacement for teeth, and millions are placed annually. With current dental implant failure rates over 16 percent and rising, patients are being subjected to highly invasive surgeries in an attempt to save these ailing and failing implants. The LAPIP™ protocol is a tissue-sparing, non-destructive, minimally invasive treatment.

About Millennium Dental Technologies
Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP® protocol for the treatment of gum disease and the manufacturer of the PerioLase® MVP-7™ digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared and patented LANAP® protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional scalpel/suture flap surgery; its PerioLase® MVP-7™ is a 6-watt free-running variable-pulsed Nd:YAG dental laser featuring digital technology and 7 pulse durations — the most available on the market — giving it the power and versatility to perform a wide range of soft- and hard-tissue laser procedures. The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the treatment of ailing and failing implants. Established in 1994, the company’s founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients — and to remain true to the guiding principle — “It’s all about the patient.” For more information, visit www.lanap.com.

About Fotona
Fotona has sold over 25,000 lasers around the world, with direct sales in the U.S, and distribution in over 60 countries. Fotona produces award winning lasers in dentistry, aesthetics, dermatology, gynecology & other medical fields. Fotona has one of the most highly educated workforces in the industry, with an exceptionally high number of PhDs specializing in laser and medical technology. Strong R&D capabilities have always been a key competitive advantage of the company, resulting in many patented solutions, including the Optoflex® articulated arm, QSP (Quantum Square Pulse) and VSP (Variable Square Pulse) technologies, Fotona SMOOTH® mode, Vacuum Cell technology, and many more.

For Further Information
This in-depth look at the dental lasers market is part of a report published by iData entitled “U.S. Market for Dental Lasers“. The full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at [email protected] for a U.S. Market for Dental Lasers report brochure and synopsis. iData covers a wide range of other dental global markets. Each of the following categories covers 16 to 25 countries. Visit the iData Research Dental Category page for more details on the following sub-segments: Dental Bone Grafts, Dental CAD / CAM, Dental Prosthetics, Dental Imaging, Dental Lasers, Dental Materials, Dental Overdentures, Dental Equipment, Dental Hygiene, Dental Instruments

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch